🔎 Trials Near Me

Gara Jalqabaatti › Kansara Qara'a Non-Small Cell › Louisiana › New Orleans

Qorannoo klinikaalii Kansara Qara'a Non-Small Cell New Orleans, LA keessatti

Qorannoo 9 Kansara Qara'a Non-Small Cell f New Orleans fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Namoota walitti qabaa jiraSadarkaa 3
  • University Medical Center New Orleans, New Orleans
  • Touro Infirmary, New Orleans
  • Ochsner Medical Center Jefferson, New Orleans
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT04267848

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Namoota walitti qabaa jiraSadarkaa 3
  • University Medical Center New Orleans, New Orleans
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06498635

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Ochsner Clinic Foundation, New Orleans
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06890598

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Tulane Cancer Center, New Orleans
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT05059444

A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • LSU Health Sciences Center School of Medicine, New Orleans
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT07361562

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Namoota walitti qabaa jiraSadarkaa 1/2
  • Local Institution - 2116, New Orleans
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 27-Cam-2026 · NCT03093116

Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)

Namoota walitti qabaa jiraSadarkaa 3
  • Tulane Cancer Center, New Orleans
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Cam-2026 · NCT07154706

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, New Orleans
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs

Namoota walitti qabaa jiraSadarkaa 1/2
  • Ochsner/MD Anderson Cancer Center, New Orleans
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Onk-2025 · NCT06228326

Qorannoo Kansara Qara'a Non-Small Cell magaalota biroo keessatti

Qorannoo biroo New Orleans keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.